Switch to full style

Forum rules

Postings here are publicly visible and searchable with search engines. If you would like more privacy, you can post in the private forum instead. Click here for more resources including in person support groups, newsletters and referral information.
Topic locked

Notice re class action lawsuit - Synergy/EMPower/Truehope

15 May 2009

Hi there,
This notice was received by BCSS for distribution and may concern your family.

Class Action Lawsuit
Synergy - EMPower - Truehope Lawsuit

If you or someone in your family has taken nutritional supplements promoted by the Synergy Group of Canada, their sales associates, and others, you may be eligible to participate in a class action lawsuit.

The product in question is E.M. Power+ (plus).
For more information go to http://www.healthwatcher.net/Quackerywa ... wsuit.html

Re: Notice re class action lawsuit - Synergy/EMPower/Truehope

15 May 2009

There are class action suits against all types of medications, including the antidepressant that caused my daughter to experience psychosis, and kick started her bipolar disorder. At one point Empower was suggested by her psychiatrist and worked about as well as lithium. One man's meat is another man's poison. Quackwatch seems to have a longstanding agenda against Truehope; their use of language is certainly loaded.

Re: Notice re class action lawsuit - Synergy/EMPower/Truehope

18 May 2009

Health Canada is advising Canadians not to use Empowerplus
June 6, 2003
For immediate release

Backgrounders: Health Canada's actions against Empowerplus see link below

OTTAWA - Health Canada is advising consumers not to use Empowerplus, also known as EM Power+ and EM Power. It is a drug - being sold by the company Truehope Nutritional Support Limited (also known as Synergy) - which has not been approved for sale in Canada. Health Canada is the federal government regulatory body that authorizes the manufacture and sale of all drugs in this country.

Health Canada has identified risks associated with the use of Empowerplus. The safety and efficacy of Empowerplus has not been shown. The drug is being sold to treat serious disorders, such as bipolar disorder, anxiety disorder, panic attacks, attention deficit disorder, schizophrenia, autism, Tourette's syndrome, fibromyalgia and obsessive compulsive disorder.

Serious central nervous system conditions are best treated under the supervision of a health care provider. These serious disorders should not be self-medicated or self-diagnosed.

Before a drug can be sold in Canada, the manufacturer must first provide Health Canada with scientific evidence that the drug is safe and effective at meeting its stated claims of effectiveness of treatment. In order that consumers can distinguish between approved and non-approved drugs in Canada, all approved drugs sold in this country carry an eight-digit Drug Identification Number (DIN) on the label.

While this product has not been found in retail stores in Canada, it is being shipped to Canadian consumers following orders taken by TrueHope. Health Canada has a directive on personal importation of drugs. The directive can be found at:
http://www.hc-sc.gc.ca/ahc-asc/branch-d ... ex-eng.php

Health Canada reminds consumers of the importance of discussing the use of any non-prescription drugs, including vitamins, minerals and herbal products, with their health care provider. This may include a physician, pharmacist or complementary or alternative practitioner.

Health Canada recognizes the difficult circumstances faced by people with serious central nervous system conditions, and understands that some may have been using Empowerplus. In recognition of the seriousness of this issue, Health Canada is working to provide these individuals with appropriate referral options to health care professionals and services, by setting up a toll-free health assistance referral line. That number is 1-800 504-4156.


For more information:
Ryan Baker
Health Canada
(613) 954-4807

Public Inquiries:
(613) 957-2991
Last edited by Mindful on 18 May 2009, edited 1 time in total.

Re: Notice re class action lawsuit - Synergy/EMPower/Truehope

18 May 2009

Reports of adverse reactions in patients with serious mental health conditions suspected in association with use of prescription medications and EMPowerPlus

Information Update
February 28, 2007
Information Update

OTTAWA - Health Canada is updating Canadians about adverse reaction reports it has received concerning the use of EMPowerplus, a vitamin mineral supplement, for serious medical conditions.

Health Canada has received nine case reports of serious adverse reactions associated with the use of EMPowerplus. Most of the adverse reactions relate to worsening of psychiatric symptoms in those patients with serious underlying mental health problems, such as bipolar disorder and depression. The worsening of these symptoms could be related to taking the product and discontinuing prescription medications or taking the product in conjunction with prescribed medications. As a result, Health Canada is advising consumers with these serious conditions that there is a potential risk to health associated with the use of the product EMPowerplus.

Health Canada is concerned about the health risk posed by this product's promotion, including unauthorized health claims, and medical advice being provided by non-medically qualified staff of Truehope Nutritional Support Ltd. to patients with serious medical conditions to discontinue their prescribed medications. This may result in serious adverse health consequences.

It is important to discuss the treatment of serious medical conditions with a medically qualified practitioner.

A Health Canada public advisory and an information bulletin were previously issued in 2003, concerning the use of EMPowerplus for the treatment of serious medical conditions. With the receipt of the adverse reactions, Health Canada remains concerned about the health risks associated with the use of this product.

Consumers requiring more information about this Health Canada Information Update can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.

To report a suspected adverse reaction with this or any other health product, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:

Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789

Marketed Health Products Directorate
Tunney's Pasture, AL 0701C
email: cadrmp@hc-sc.gc.ca

Re: Notice re class action lawsuit - Synergy/EMPower/Truehope

18 May 2009

I don't think this forum is the place for wrangle about Empower or any other treatment - that is best left between the patient and health care provider. There are black box warnings on antidepressants, every medication food and food supplement can cause adverse reactions for some, and there are class action suits against most, if not all drug manufacturers, involving most, if not all psychoactive medications. If this is the direction this thread is going, all of the class action suits should be posted here, not just one.

Re: Notice re class action lawsuit - Synergy/EMPower/Truehope

18 May 2009

This is the first notice of a class action lawsuit I've received for posting. I've closed this thread since the purpose of this board is more about support than 'wrangling'. Thanks to everyone who've provided information and perspectives.
Topic locked